Description: Nautilus Biotechnology, Inc. operates as biotech company that develops a platform using computational techniques, cloud computing, AI technologies, and blood tests to detect cancer and potentially other health issues at an early stage. Nautilus Biotechnology, Inc. was formerly known as Ignite Biosciences, Inc. The company was incorporated in 2016 and is based in San Carlos, California.
Home Page: www.nautilus.bio
NAUT Technical Analysis
2701 Eastlake Avenue East
Seattle,
WA
98102
United States
Phone:
206 333 2001
Officers
| Name | Title |
|---|---|
| Mr. Sujal M. Patel | Co-Founder, CEO, Pres, Sec. & Director |
| Dr. Parag Mallick Ph.D. | Co-Founder, Chief Scientist & Director |
| Mr. Matthew B. Murphy ESQ. | Gen. Counsel |
| Ms. Anna Mowry | CFO & Treasurer |
| Ms. Mary E. Godwin | Sr. VP of Operations |
| Mr. Chris Blessington | VP of Corp. Marketing & Communications |
| Ms. Gwen E. Weld | Chief People Officer |
| Mr. Nick A. Nelson | Chief Bus. Officer & Sr. VP of Bus. Devel. |
| Dr. Subra Sankar Ph.D. | Sr. VP of Product Devel. |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.6211 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2021-06-10 |
| Fiscal Year End: | December |
| Full Time Employees: | 127 |